Overview
Compare with ENTREPRENEUR UNIVERSE BRIGHT GROUP, DATZ WORLD HOLDINGS CORP. or Acco Group Holdings Ltd, or pick any stock.
- TickerDFNS on Nasdaq1
- IndustryServices-Management Consulting Services1
- HeadquartersNew York, New York1
- Incorporated inDE2
- Business address575 Fifth Avenue, 14Th Floor, New York, Ny 100172
- Filer category, Emerging growth company2
- Legal formCorporation
See how the biggest companies compare on our leaderboards
Combination, Brilliant changed its name to “Nukkleus Inc.” The Business Combination was completed on December 22, 2023.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Cost of revenue83¢$4.9M
- Other costs17¢$998.5K
Out of $5.9M in revenue.45 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years (annual) or 1 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-09-30 |
|---|---|---|
| Impairment loss | -$4.3M | -$391.0K |
| General and administrative expenses (Note 15) | -$28.1M | -$6.7M |
| General and administrative expenses of consolidated variable interest entities | -$174.0K | |
| Total operating expenses | -$32.6M | -$7.1M |
| Loss from operations | -$32.6M | -$7.1M |
| Financial expense, net | -$154.0K | -$387.0K |
| Interest income of consolidated variable interest entities | $279.0K | |
| Loss on settlement of vendor obligations | -$289.0K | |
| Gain on settlement of vendor obligations | $211.0K | |
| Loss on shares issued as commitment for ELOC agreement | -$1.2M | |
| Gain on settlement of due to affiliates | $192.0K | |
| Loss on debt extinguishment | -$7.5M | |
| Penalties on late registration | -$1.1M | |
| Change in fair value - convertible note embedded derivative | $588.0K | |
| Change in fair value - stock purchase warrant liabilities | $131.8M | |
| Day one loss on private placement | -$13.4M | |
| Total other income (expense), net | $109.2M | -$273.0K |
| Net income (loss) before income taxes | $76.6M | -$7.4M |
| Income taxes | -$9.0K | |
| Net income (loss) from continuing operation | $76.6M | -$7.4M |
| Net gain (loss) from discontinued operations (Note 3) | $2.0M | -$1.1M |
| Net income (loss) | $78.6M | -$8.5M |
| Net income attributable to non-controlling interests | $82.0K | |
| Net income attributable to the Companys stockholders | $78.5M | -$8.5M |
| Earnings (loss) per share from continuing operations (basic) (in Dollars per share) | $8 | -$4 |
| Earnings (loss) per share from discontinued operations (basic) (in Dollars per share) | $0 | -$1 |
| Total loss per share (basic) (in Dollars per share) | $8.45 | -$4.93 |
| Weighted average number of shares of Common Stock outstanding - basic (*) (Note 17) (in Shares) | 8.4M shares | 1.7M shares |
| Earnings (loss) per share from continuing operations (diluted) (in Dollars per share) | $8 | -$4 |
| Earnings (loss) per share from discontinued operations (diluted) (in Dollars per share) | $0 | -$1 |
| Total gain per share (diluted) (in Dollars per share) | $7.96 | -$4.93 |
| Weighted average number of shares of Common Stock outstanding diluted (Note 17) (in Shares) | 9.2M shares | 1.7M shares |
| Period ending | 2024-12-31 |
|---|---|
| General and administrative expenses (Note 15) | -$4.5M |
| Total operating expenses | -$4.5M |
| Loss from operations | -$4.5M |
| Financial expense, net | -$439.0K |
| Loss on settlement of vendor obligations | -$278.0K |
| Change in fair value - convertible note embedded derivative | -$625.0K |
| Change in fair value - stock purchase warrant liabilities | -$140.6M |
| Day one loss of stock purchase warrants issued in connection with conversion of convertible notes | -$663.0K |
| Day one loss on private placement | -$13.5M |
| Other income | $18.0K |
| Total other income (expense), net | -$156.1M |
| Net income (loss) before income taxes | -$160.6M |
| Net income (loss) from continuing operation | -$160.6M |
| Net gain (loss) from discontinued operations (Note 3) | -$158.0K |
| Net income (loss) | -$160.8M |
| Net income attributable to the Companys stockholders | -$160.8M |
| Earnings (loss) per share from continuing operations (basic) (in Dollars per share) | -$52 |
| Earnings (loss) per share from discontinued operations (basic) (in Dollars per share) | -$0 |
| Total loss per share (basic) (in Dollars per share) | -$51.96 |
| Weighted average number of shares of Common Stock outstanding - basic (*) (Note 17) (in Shares) | 3.1M shares |
| Earnings (loss) per share from continuing operations (diluted) (in Dollars per share) | -$52 |
| Earnings (loss) per share from discontinued operations (diluted) (in Dollars per share) | -$0 |
| Total gain per share (diluted) (in Dollars per share) | -$51.96 |
| Weighted average number of shares of Common Stock outstanding diluted (Note 17) (in Shares) | 3.1M shares |
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $2.6M | $6.9M | ||
| Cash and cash equivalents | $1.3M | |||
| Other current assets | $102.0K | |||
| Restricted cash | $50.0K | |||
| Marketable Securities | $250.0K | |||
| Accounts receivable, less allowance for credit losses of $27 as of December 31, 2025 | $506.0K | |||
| Other current assets (Note 5) | $224.0K | $107.0K | ||
| Loan granted (Note 6) | $2.4M | |||
| Current assets from discontinued operations (Note 3) | $1.1M | |||
| Total Current assets | $13.6M | $9.1M | ||
| Intangible assets (Note 7) | $16.0K | |||
| Operating right of use assets (Note 8) | $823.0K | |||
| Cash and securities held in trust account (Note 1D) | $172.8M | |||
| Other non-current assets | $36.0K | |||
| Property and equipment, net | $101.0K | |||
| Goodwill (Note 4) | $7.7M | |||
| Other intangible asset (Note 4) | $7.4M | |||
| Non-Current assets from discontinued operations (Note 3) | $15.0K | |||
| Total Non-Current assets | $188.8M | $15.0K | ||
| Total Assets | $202.4M | $9.1M | ||
| Short term loan | $12.0K | |||
| Accounts payable | $124.0K | $70.0K | ||
| Operating lease liability, current portion (Note 8) | $504.0K | |||
| Convertible notes payable, net (Note 9) | $706.0K | |||
| Note payable, net | $64.0K | |||
| Due to related parties | $255.0K | $42.0K | ||
| Other current liabilities (Note 10) | $3.1M | $1.2M | ||
| Other current liabilities of consolidated variable interest entities | $104.0K | |||
| Loans payable - former related parties, current (Note 11) | $842.0K | $619.0K | ||
| Stock purchase warrant liabilities | $24.5M | $164.8M | ||
| Deferred considerations (Note 4) | $14.1M | |||
| Derivative liability | $848.0K | |||
| Current liabilities from discontinued operations (Note 3) | $3.2M | |||
| Total current liabilities | $43.5M | $171.4M | ||
| Non-current operating lease liabilities (Note 8) | $143.0K | |||
| Loan payable - former related parties, net of current portion (Note 11) | $850.0K | $992.0K | ||
| Deferred tax liability (Note 4) | $647.0K | |||
| Non-current liabilities from discontinued operations (Note 3) | $17.0K | |||
| Total Non-Current liabilities | $1.6M | $1.0M | ||
| Total Liabilities | $45.2M | $172.5M | ||
| Noncontrolling interests Subject to Possible Redemption (Note 1D) | $172.8M | |||
| Common stock ($0.0001 par value; 150,000,000 shares authorized; 19,025,767 and 4,930,531 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively) | $2.0K | |||
| Additional paid-in capital | $102.7M | $37.8M | ||
| Accumulated other comprehensive (loss) | -$34.0K | |||
| Accumulated deficit | -$122.5M | -$201.1M | ||
| Total Companys stockholders deficit | -$19.8M | -$163.3M | ||
| Non-controlling interest | $4.2M | |||
| Total stockholders deficit | -$15.6M | -$163.3M | -$7.1M | -$6.2M |
| Total liabilities and stockholders deficit | $202.4M | $9.1M | ||
| Accounts receivable allowance for credit losses | $27.0K | |||
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in Shares) | 15.0M shares | 15.0M shares | ||
| Preferred stock, shares issued (in Shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in Shares) | 0 shares | 0 shares | ||
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in Shares) | 150.0M shares | 150.0M shares | ||
| Common stock, shares issued (in Shares) | 19.0M shares | 4.9M shares | ||
| Common stock, shares outstanding (in Shares) | 19.0M shares | 4.9M shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2024-09-30 | 2023-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | $2.6M | $6.9M | ||
| Cash and cash equivalents | $1.3M | |||
| Other current assets | $102.0K | |||
| Restricted cash | $50.0K | |||
| Marketable Securities | $250.0K | |||
| Accounts receivable, less allowance for credit losses of $27 as of December 31, 2025 | $506.0K | |||
| Other current assets (Note 5) | $224.0K | $107.0K | ||
| Loan granted (Note 6) | $2.4M | |||
| Current assets from discontinued operations (Note 3) | $1.1M | |||
| Total Current assets | $13.6M | $9.1M | ||
| Intangible assets (Note 7) | $16.0K | |||
| Operating right of use assets (Note 8) | $823.0K | |||
| Cash and securities held in trust account (Note 1D) | $172.8M | |||
| Other non-current assets | $36.0K | |||
| Property and equipment, net | $101.0K | |||
| Goodwill (Note 4) | $7.7M | |||
| Other intangible asset (Note 4) | $7.4M | |||
| Non-Current assets from discontinued operations (Note 3) | $15.0K | |||
| Total Non-Current assets | $188.8M | $15.0K | ||
| Total Assets | $202.4M | $9.1M | ||
| Short term loan | $12.0K | |||
| Accounts payable | $124.0K | $70.0K | ||
| Operating lease liability, current portion (Note 8) | $504.0K | |||
| Convertible notes payable, net (Note 9) | $706.0K | |||
| Note payable, net | $64.0K | |||
| Due to related parties | $255.0K | $42.0K | ||
| Other current liabilities (Note 10) | $3.1M | $1.2M | ||
| Other current liabilities of consolidated variable interest entities | $104.0K | |||
| Loans payable - former related parties, current (Note 11) | $842.0K | $619.0K | ||
| Stock purchase warrant liabilities | $24.5M | $164.8M | ||
| Deferred considerations (Note 4) | $14.1M | |||
| Derivative liability | $848.0K | |||
| Current liabilities from discontinued operations (Note 3) | $3.2M | |||
| Total current liabilities | $43.5M | $171.4M | ||
| Non-current operating lease liabilities (Note 8) | $143.0K | |||
| Loan payable - former related parties, net of current portion (Note 11) | $850.0K | $992.0K | ||
| Deferred tax liability (Note 4) | $647.0K | |||
| Non-current liabilities from discontinued operations (Note 3) | $17.0K | |||
| Total Non-Current liabilities | $1.6M | $1.0M | ||
| Total Liabilities | $45.2M | $172.5M | ||
| Noncontrolling interests Subject to Possible Redemption (Note 1D) | $172.8M | |||
| Common stock ($0.0001 par value; 150,000,000 shares authorized; 19,025,767 and 4,930,531 shares issued and outstanding at December 31, 2025 and December 31, 2024, respectively) | $2.0K | |||
| Additional paid-in capital | $102.7M | $37.8M | ||
| Accumulated other comprehensive (loss) | -$34.0K | |||
| Accumulated deficit | -$122.5M | -$201.1M | ||
| Total Companys stockholders deficit | -$19.8M | -$163.3M | ||
| Non-controlling interest | $4.2M | |||
| Total stockholders deficit | -$15.6M | -$163.3M | -$7.1M | -$6.2M |
| Total liabilities and stockholders deficit | $202.4M | $9.1M | ||
| Accounts receivable allowance for credit losses | $27.0K | |||
| Preferred stock, par value (in Dollars per share) | $0.00 | $0.00 | ||
| Preferred stock, shares authorized (in Shares) | 15.0M shares | 15.0M shares | ||
| Preferred stock, shares issued (in Shares) | 0 shares | 0 shares | ||
| Preferred stock, shares outstanding (in Shares) | 0 shares | 0 shares | ||
| Common stock, par value (in Dollars per share) | $0.00 | $0.00 | ||
| Common stock, shares authorized (in Shares) | 150.0M shares | 150.0M shares | ||
| Common stock, shares issued (in Shares) | 19.0M shares | 4.9M shares | ||
| Common stock, shares outstanding (in Shares) | 19.0M shares | 4.9M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years (annual) or 1 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-09-30 |
|---|---|---|
| Net income (loss) for the year from continuing operations | $78.6M | -$8.5M |
| Net gain (loss) from discontinued operations | $2.0M | -$1.1M |
| Net gain (loss) for the year from continuing operation | $76.6M | -$7.4M |
| Amortization of debt discount | $316.0K | |
| Depreciation | $4.0K | |
| Stock-based compensation | $18.8M | $230.0K |
| Interest earned on marketable securities held in Trust Account | -$278.0K | |
| Loss on extinguishment of vendor obligations | $289.0K | |
| Gain on extinguishment of vendor obligations | -$211.0K | |
| Gain on extinguishment of affiliates liabilities due to | -$192.0K | |
| Impairment loss | $4.3M | $391.0K |
| Loss on extinguishment of convertible notes payable | $7.1M | |
| Shares and warrants issued in connection with JV agreement | $2.8M | |
| Shares issued as part of settlement agreement | $157.0K | |
| Shares issued as penalty for filing | $300.0K | |
| Shares issued as commitment for ELOC agreement | $1.2M | |
| Gain on marketable securities | -$301.0K | |
| Day one loss on stock purchase warrants issued in connection with private placement | $13.4M | |
| Change in fair value - stock purchase warrant liabilities | -$130.1M | |
| Change in fair value of liability-classified stock purchase warrants | -$588.0K | |
| Changes in lease assets and lease liabilities | -$151.0K | |
| Other current assets | -$264.0K | -$236.0K |
| Accounts payable | $30.0K | |
| Due to affiliates | $2.9M | |
| Interest payable - related parties | -$34.0K | $44.0K |
| Accrued expenses and other current liabilities | $760.0K | $2.9M |
| Net cash used in operating activities continuing operations | -$6.1M | -$893.0K |
| Net cash used in operating activities discontinuing operations | -$51.0K | -$2.9M |
| Net cash used in operating activities | -$6.2M | -$3.8M |
| Investment in short term securities | $50.0K | |
| Loan granted | -$2.4M | |
| Investment of cash in Trust Account | -$172.5M | |
| Due to affiliates, net | -$984.0K | |
| Cash provided by purchase of subsidiary | $449.0K | |
| Payment on property and equipment | -$31.0K | |
| Advance to target of planned acquisition | -$3.5M | |
| Net cash used in investing activities continuing operations | -$178.9M | |
| Net cash used in investing activities discontinuing operations | -$960.0K | $133.0K |
| Net cash used in investing activities | -$179.8M | $133.0K |
| Business Combination, net of issuance costs | $150.0K | |
| Proceeds from issuance of loans payable - related parties | $1.4M | |
| Proceeds from issuance of private placement and embedded derivative, net of issuance costs | $9.2M | |
| Proceeds from sale of SPAC Units and Private Placement Units, net of issuance costs | $172.9M | |
| Repayments on loans payable - related parties | -$94.0K | |
| Proceeds from issuance of convertible notes payable and stock purchase warrants, net of issuance costs | $996.0K | |
| Proceeds from issuance of note payable and stock purchase warrants | $78.0K | |
| Net cash provided by financing activities continuing operations | $182.0M | $2.6M |
| Net cash provided by financing activities discontinuing operations | $422.0K | |
| Net cash provided by financing activities | $182.0M | $3.0M |
| Effect of exchange rate changes on cash and cash equivalents continuing operations | $95.0K | $29.0K |
| Effect of exchange rate changes on cash and cash equivalents discontinuing operations | $34.0K | |
| INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | -$3.9M | -$656.0K |
| Interest | $1.0K | |
| Issuance of common stock to settle loans payable related parties and accrued and unpaid interest | $613.0K | |
| Capital reduction on settlement of loans payable related parties and accrued and unpaid interest through issuance of common stock | -$343.0K | |
| Issuance of common stock to settle due to affiliates | $6.6M | |
| Capital reduction on settlement of due to affiliates through issuance of common stock | -$3.9M | |
| Issuance of common stock to settle accrued expenses and other current liabilities | $1.9M | |
| Settlement of due to affiliates through issuance of loan payable related parties | $1.2M | |
| Settlement of accrued expenses and other current liabilities through issuance of Old Nukk common stock | $213.0K | |
| Issuance of Old Nukk common stock to Brilliant vendors in exchange for receivable from Brilliant | $1.8M | |
| Settlement of loans payable related parties through exchange of notes receivable related parties and accrued and unpaid interest | $38.0K | |
| Settlement of loans payable related parties through exchange of due from affiliates | $12.0K | |
| Issuance of common stock for digital assets purchased | $4.4M | |
| Initial recognition of operating lease liability and a corresponding right-of- use asset | $695.0K | |
| Fair value of the derivative liability extinguished from conversion of convertible note | $260.0K | |
| Fair value of warrants exercised | $31.9M | |
| Share issued to cover subsidiary's liabilities | $509.0K | |
| Offering costs included in accrued offering costs | $76.0K | |
| Fair value of common stock issued in connection with conversion of convertible note | $1.5M |
| Period ending | 2024-12-31 |
|---|---|
| Net income (loss) for the year from continuing operations | -$160.8M |
| Net gain (loss) from discontinued operations | -$158.0K |
| Net gain (loss) for the year from continuing operation | -$160.6M |
| Amortization of debt discount | $414.0K |
| Stock-based compensation | $6.0K |
| Loss on extinguishment of vendor obligations | $278.0K |
| Gain on deconsolidation | -$64.0K |
| Day one loss on stock purchase warrants issued in connection with private placement | $13.5M |
| Change in fair value - stock purchase warrant liabilities | $663.0K |
| Change in fair value of liability-classified stock purchase warrants | $140.6M |
| Change in fair value of derivative liabilities | $625.0K |
| Loss on reclassification of stock purchase warrants from equity-classified to liability-classified | $46.0K |
| Other current assets | $136.0K |
| Accounts payable | $70.0K |
| Interest payable - related parties | $21.0K |
| Accrued expenses and other current liabilities | $2.9M |
| Net cash used in operating activities continuing operations | -$1.5M |
| Net cash used in operating activities discontinuing operations | $1.1M |
| Net cash used in operating activities | -$340.0K |
| Proceeds from sale of investment | $64.0K |
| Advance to target of planned acquisition | -$1.0M |
| Net cash used in investing activities continuing operations | -$936.0K |
| Net cash used in investing activities | -$936.0K |
| Proceeds from issuance of private placement and embedded derivative, net of issuance costs | $9.1M |
| Proceeds from issuance of common stock, net of issuance costs | $478.0K |
| Repayments on loans payable - related parties | -$1.0M |
| Proceeds from issuance of convertible notes payable and embedded derivative, net of issuance costs | $450.0K |
| Net cash provided by financing activities continuing operations | $9.1M |
| Net cash provided by financing activities | $9.1M |
| Effect of exchange rate changes on cash and cash equivalents continuing operations | $36.0K |
| INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH | $7.8M |
| Issuance of common stock to settle accrued expenses and other current liabilities | $760.0K |
| Fair value of the stock purchase warrants issued in connection with the private placement agreement | $23.2M |
| Issuance of common stock issued as compensation for services | $1.4M |
| Issuance of common stock issued to settle Exit and Settlement Agreement | $325.0K |
| Issuance of common stock issued as compensation to board of directors | $959.0K |
| Fair value of derivative liability embedded within convertible note payable | -$848.0K |
| Fair value of liability-classified warrants issued in connection with conversion of convertible notes | -$663.0K |
| Settlement of convertible notes payable through issuance of common stock | $771.0K |
| Fair value of stock purchase warrants reclassified from equity-classified to liability-classified | -$283.0K |
Corporate structure
T3 Defense Inc. sits at the top of its group. 1 entity, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of T3 Defense Inc.
- Elad Shohat Filed SCHEDULE 13D on T3 Defense Inc., latest Jul 24, 2026
- Menachem Shalom Filed SCHEDULE 13D/A on T3 Defense Inc., latest Apr 28, 2026 (2 filings since Jan 20, 2026)
- Esousa Group Holdings LLC Filed SCHEDULE 13G/A on T3 Defense Inc., latest Feb 17, 2026 (5 filings since Dec 23, 2024)
- Hudson Bay Capital Management LP Filed SC 13G/A on T3 Defense Inc., latest Feb 7, 2023 (2 filings since Feb 8, 2022)
- Karpus Management, Inc. Filed SC 13G/A on T3 Defense Inc., latest Nov 10, 2022 (2 filings since Feb 14, 2022)
- Lawrence Feis Filed SC 13G/A on T3 Defense Inc., latest Aug 5, 2022 (2 filings since Jan 11, 2022)
- GLAZER CAPITAL, LLC Filed SC 13G/A on T3 Defense Inc., latest Feb 14, 2022
- T3 Defense Inc. New York, New York
Built from major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What T3 Defense Inc. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, net | $101.0K5 Dec 31, 2025 | ||
| Operating-lease assets (leased space) | $823.0K5 Dec 31, 2025 |
Real estate and locations
| Item | Latest | A year before | Change |
|---|---|---|---|
| Area of land | 25 Dec 31, 2025 |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $2.6M5 Dec 31, 2025 | $6.9M5 Dec 31, 2024 | −61.9% |
| Marketable securities, current | $250.0K5 Dec 31, 2025 |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $7.7M5 Dec 31, 2025 | ||
| Intangible assets, net (excluding goodwill) | $16.0K5 Dec 31, 2025 | ||
| Finite-lived intangibles, gross | $11.3M4 Sep 30, 2024 | $11.3M4 Sep 30, 2023 | 0% |
| Accumulated amortization | $5.6M4 Sep 30, 2024 | $5.5M4 Sep 30, 2023 | +0.2% |
| Finite-lived intangibles, net | $19.3K4 Sep 30, 2024 | $33.0K4 Sep 30, 2023 | −41.5% |
Properties, in its own words
The Company’s headquarters are located in New York, New York. On January 2, 2025, we entered into a one-year lease for virtual office space located at 575 Fifth Avenue, 14th Floor, New York, New York 10017. The lease is for $1,200 per month and automatically renews for one-month terms unless cancelled in accordance with the terms and conditions of the lease. The Company’s office which it shares with Nukk Picolo, its Israeli wholly-owned subsidiary, is located at 8 Hagavish, Netanya under a lease which expires in December 2026. The monthly lease payments under the lease agreement are approximately NIS 49,000 (approximately $16,000).
Rimon’s has 2 lease agreements for its offices as follows: 10 Hamelacha, Netanya, Israel expires in April 2028. The monthly lease payments under the lease agreement are approximately NIS 32,000 (approximately $10,000). The lease for the space at 14 Yad Harutzim, Netanya, Israel expires in January 2027. The monthly lease payments under the lease agreement are approximately NIS 40,000 (approximately $11,000).
The rest of Item 2
Tiltan offices are located in 4 Granit, Petach Tikva under a lease agreement which expires in December 2026. The monthly lease payments are approximately NIS 34,000 (approximately $11,000).
ITS offices are located in 5 Atir Yeda, Kfar Saba under a lease agreement which expires in January 2027. The monthly lease payments under the lease agreement are approximately NIS 185,000 (approximately $60,000).
Positech offices are located in 4 Hapeles, Haifa under a lease agreement which expires in April 2034. The monthly lease payments under the lease agreement are approximately NIS 23,000 (approximately $7,400).
We currently own no real property. We believe our facilities are adequate for our current and planned business operations.
Item 2 of the 10-K filed Apr 9, 2026.3
Leadership
Who has led T3 Defense Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
- Chief executive officerMenachem Shalom Sep 25, 2024 to Dec 20, 202412
- Chief executive officerAnastasiia Kotaieva Dec 20, 2024 to now13
- Chief executive officerAviya Volodarsky Dec 20, 2024 to now14
- Chief executive officerDavid Rokach Dec 20, 2024 to now15
- Chief executive officerReuven Yeganeh Dec 20, 2024 to now16
- Chief financial officerRoy Cohen Jun 11, 2026 to now17
Board members and other officers (8)
- Board memberTomer Nagar Nov 20, 2025 to now18
- Board memberMenachem Shalom Sep 25, 2024 to now12
- Board memberAnastasiia Kotaieva Dec 20, 2024 to now13
- Board memberAviya Volodarsky Dec 20, 2024 to now14
- Board memberDavid Rokach Dec 20, 2024 to now15
- Board memberReuven Yeganeh Dec 20, 2024 to now16
- Board memberBrian Ferrier Mar 11, 2022 to Apr 20, 202219
- Board memberYebo Shen Mar 11, 2022 to Apr 21, 202220
Named in SEC Form D filings
People the company listed in its private-offering notices.
- CFOMorel Levi named Mar 10, 202621
Former names
Timeline
- Oct 7, 20268-K Executive or director change22
- Sep 11, 20268-K New debt or obligation23
- Sep 10, 20268-K Other events24
- Aug 31, 20268-K Ended a material agreement; Other events25
- Aug 20, 20268-K Listing notice or transfer26
- Aug 17, 20268-K Other events27
- Aug 6, 20268-K Shareholder vote28
- Jul 16, 20268-K Change to shareholders' rights; Bylaws or fiscal year changed29
- Jul 15, 20268-K Other events30
- Jul 13, 20268-K Change to shareholders' rights; Bylaws or fiscal year changed31
- Jul 9, 20268-K Completed an acquisition or sale32
- Jun 29, 20268-K Shareholder vote33
- Dec 20, 2024New chief executive Reuven Yeganeh becomes CEO16
- Dec 20, 2024New chief executive David Rokach becomes CEO15
- Dec 20, 2024New chief executive Aviya Volodarsky becomes CEO14
- Dec 20, 2024New chief executive Anastasiia Kotaieva becomes CEO13
- Sep 25, 2024New chief executive Menachem Shalom becomes CEO12
Calendar
When it reported results
- Apr 15, 2026Reported quarterly or annual results34
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
355 filings to the SEC since October 2021: 10 annual reports, 18 quarterly reports, 129 major events, 29 insider forms, 20 large holders, 3 private raises, 146 other. The latest 20:
- Oct 7, 20268-K EDGAR
- Oct 2, 2026S-1/A EDGAR
- Oct 2, 2026S-1/A EDGAR
- Oct 2, 2026S-3/A EDGAR
- Sep 15, 2026SCHEDULE 13D/A EDGAR
- Sep 15, 2026S-3 EDGAR
- Sep 11, 20268-K EDGAR
- Sep 10, 20268-K EDGAR
- Sep 3, 2026S-1 REGISTRATION STATEMENT EDGAR
- Sep 3, 2026S-1 EDGAR
- Aug 31, 20268-K EDGAR
- Aug 20, 20268-K EDGAR
- Aug 18, 202610-Q EDGAR
- Aug 17, 20268-K EDGAR
- Aug 14, 2026NT 10-Q EDGAR
- Aug 10, 2026S-8 EDGAR
- Aug 6, 20268-K EDGAR
- Aug 3, 2026DRS EDGAR
- Jul 31, 2026DRS EDGAR
- Jul 30, 2026DRS EDGAR
The 355 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
12 open-market trades by officers, directors and large owners since October 2021: 4 buys and 8 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Dec 30, 2025 | Kotaieva Anastasiia | Sale | 75,000 | $4.03 | $302.2K | Form 4 |
| Dec 29, 2025 | Kotaieva Anastasiia | Sale | 75,000 | $4.09 | $306.8K | Form 4 |
| Dec 26, 2025 | Kotaieva Anastasiia | Sale | 55,604 | $4.26 | $236.9K | Form 4 |
| Dec 24, 2025 | Kotaieva Anastasiia | Sale | 55,604 | $4.49 | $249.7K | Form 4 |
| Dec 23, 2025 | Kotaieva Anastasiia | Sale | 70,000 | $4.57 | $319.9K | Form 4 |
| Dec 22, 2025 | Kotaieva Anastasiia | Sale | 30,000 | $4.41 | $132.3K | Form 4 |
| Dec 19, 2025 | Kotaieva Anastasiia | Sale | 70,000 | $4.53 | $317.1K | Form 4 |
| Dec 18, 2025 | Kotaieva Anastasiia | Sale | 38,744 | $4.72 | $182.9K | Form 4 |
| Oct 9, 2025 | Kotaieva Anastasiia | Buy | 1,259,853 | Form 4 | ||
| Oct 8, 2025 | Kotaieva Anastasiia | Buy | 117,568 | Form 4 | ||
| Nov 8, 2024 | Kotaieva Anastasiia | Buy | 319,952 | $2.41 | $771.1K | Form 4 |
| Nov 8, 2024 | Kotaieva Anastasiia | Buy | 319,952 | $2.41 | $771.1K | Form 4 |
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Elad ShohatSCHEDULE 13D, 1 filing Jul 24, 202635
- Menachem ShalomSCHEDULE 13D/A, 2 filings Jan 20, 2026 to Apr 28, 202636
- Esousa Group Holdings LLCSCHEDULE 13G/A, 5 filings Dec 23, 2024 to Feb 17, 202637
- Hudson Bay Capital Management LPSC 13G/A, 2 filings Feb 8, 2022 to Feb 7, 202338
- Karpus Management, Inc.SC 13G/A, 2 filings Feb 14, 2022 to Nov 10, 202239
- Lawrence FeisSC 13G/A, 2 filings Jan 11, 2022 to Aug 5, 202240
- GLAZER CAPITAL, LLCSC 13G/A, 1 filing Feb 14, 202241
Executive pay
What the company paid its top executives, from the summary compensation table in its proxy statement. Total pay includes salary, bonus, stock and option awards and other pay, as the company valued them.
| Year | Executive | Age | Salary | Total pay |
|---|---|---|---|---|
| 2025 | Menachem Shalom | 50 | $310.0K | $4.0M42 |
| 2025 | Morel Levi | $5.8K | $30.0K42 | |
| 2024 | CEO | $80.0K | $783.3K42 |
Money raised
Private offerings the company reported to the SEC on Form D.
SEC filer profile
How T3 Defense Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGART3 Defense Inc.1
- CIK0001787518
- Employer ID (EIN)38-39128453
- Filer statusNon-accelerated filer an emerging growth company; a smaller reporting company; not a shell company3
- Incorporated inDelaware3
- Fiscal year endsDecember 311
- Industry code (SIC)8742 Services-Management Consulting Services1
- SEC reviewing officeOffice of Trade & Services, Division of Corporation Finance1
- Business address575 Fifth Avenue, 14Th Floor, New York, NY 100171
- Phone212-791-46631
- Shares outstanding1,663,806 as of Aug 14, 202611
- Public float$40.3M as of Jun 30, 20253
- AuditorSomekh Chaikin, Tel Aviv, Israel PCAOB ID 1057; no auditor attestation of internal control over financial reporting3
- On EDGAR sinceNov 26, 20191
- Filings387 in all: 8-K (135), 425 (31), 4 (21), 10-Q (19), CORRESP (13), UPLOAD (13), DEF 14A (12), NT 10-Q (10)1
All 45 form types
3 (9), PRE 14A (9), DEFA14A (8), DRS (8), S-1 (8), S-1/A (8), PRER14A (7), SC 13G (7), 10-K (6), EFFECT (6), SC 13G/A (6), 424B3 (5), NT 10-K (5), S-4/A (4), SCHEDULE 13G/A (4), 8-K/A (3), D (3), SCHEDULE 13D (3), SCHEDULE 13D/A (3), 10-K/A (2), S-8 (2), SCHEDULE 13G (2), 10-KT (1), 10-KT/A (1), 10-Q/A (1), 25-NSE (1), 4/A (1), 424B4 (1), 8-A12B (1), CERT (1), DEFR14A (1), DRS/A (1), DRSLTR (1), RW (1), S-3 (1), S-3/A (1), S-4 (1)
- Latest filingsAnnual report (10-K) Apr 9, 2026
Quarterly report (10-Q) Aug 18, 2026
Proxy statement (DEF 14A) Jul 9, 2026
Latest 8-K (8-K) Oct 7, 2026
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, $0.0001 par value per share | DFNS | Nasdaq |
| Warrants, each warrant exercisable for one Share of Common Stock for $92.00 per share | DFNSW | Nasdaq |
From the cover page of the 10-K filed Apr 9, 2026 (Section 12(b) of the Exchange Act).3
Risk factors and legal proceedings
The risks T3 Defense Inc. names in Item 1A of its 10-K filed Apr 9, 2026: 66 risks under these headings, as written.3
- Risks Related to Our Business
- The audited consolidated financial statements included in this Annual Report have been prepared assuming the Company will continue as a going concern.
- Our unprecedented transformation from financial technology to aerospace and defense lacks any operational track record and may completely fail.
- We are attempting to integrate multiple defense companies simultaneously without any aerospace and defense experience.
- Our Chief Executive Officer’s commitments to other companies may limit his ability to devote full-time attention to our business and could result in competition or conflicts of interest, which could adversely affect our operations and financial performance.
- If we do not effectively manage our growth and the associated demands on our operational, risk management, sales and marketing, technology, compliance and finance and accounting resources, our business may be adversely impacted.
- We have divested our financial technology business and are now building a defense business, creating operational complexity and execution risk.
- We are subject to heightened operational and cybersecurity risks.
- Our pivot from fintech to the defense sector exposes us to new operational, regulatory, and market risks for which we have limited prior experience.
- We have an exclusive distribution agreement with an Israeli supplier, and any termination, non-renewal, or disruption in this relationship could severely impact our operations.
- Our minimum purchase and revenue commitments under the BladeRanger distribution agreement creates financial risks, including potential cash flow strains and inventory overhang.
- We have entered into an exclusive distribution agreement with minimum purchase and revenue commitments that we may be unable to meet, which could result in the loss of exclusivity or termination of these agreements, materially harming our business and financial condition.
The other 55 risks
- Any significant disruption in our technology could adversely impact our brand and reputation and our business, operating results, and financial condition.
- We rely on third parties in critical aspects of our business, which creates additional risk. Our ability to offer our services depends on relationships with other financial services institutions and entities, and our inability to maintain existing relationships or to enter into new such relationships could impact our ability to offer services to customers.
- Risks Related to the Defense Industry
- We lack the facility security clearances and cleared personnel required for 90% of U.S. defense contracts.
- Fixed-price defense contracts expose us to unlimited losses without cost estimation experience.
- Export control violations could result in criminal prosecution and permanent debarment.
- We face overwhelming competition from established prime contractors.
- We must comply with complex defense regulations without any infrastructure.
- Our defense distribution business is subject to complex export control laws and regulations, including ITAR and EAR, and failure to comply could result in significant fines, loss of export privileges, and reputational damage.
- Dependence on government and homeland security customers exposes us to risks associated with budget constraints, procurement processes, and policy changes.
- The defense procurement process is lengthy, complex, and highly competitive, which may prevent us from achieving the revenue targets required under our distribution agreements.
- We face potential liability and indemnification obligations related to the defense products we distribute, which could expose us to significant financial losses.
- Risks Related to Geopolitical and Macroeconomic Conditions
- Risks Related to the Ongoing Conflict in Israel and Regional Instability
- The ongoing “Swords of Iron” war and the broader military conflict in the Middle East have had, and may continue to have, a material adverse effect on our Israeli operations, supply chains, personnel, and ability to execute our business strategy.
- Mandatory military reserve duty obligations have resulted in, and may continue to result in, significant personnel shortages that disrupt our operations, production schedules, and ability to fulfill contractual obligations.
- Escalating global conflicts, particularly the ongoing wars in the Middle East and Ukraine, create both heightened demand and severe operational risks for our business.
- We do not carry war risk insurance for our Israeli operations, and losses arising from military conflict would be entirely unrecovered.
- The conflict has resulted in limitations on exports to Israel, attacks on defense companies by anti-Israeli organizations, and reputational risks that may impair our ability to conduct international business.
- Our business partners, customers, and suppliers may invoke force majeure or otherwise fail to perform their contractual obligations as a result of the conflict, which could disrupt our operations and revenue.
- Rising global defense spending may not translate into revenue for our company, and shifts in government budget priorities could adversely affect demand for our products and services.
- U.S. trade policy, including tariffs and export restrictions, may increase our costs, disrupt our supply chains, and limit our market access.
- Intensifying great-power competition and the fragmentation of international trade and security frameworks create systemic risks to our business model.
- Our Israeli operations face active military conflict without war risk insurance.
- Operating across multiple jurisdictions creates irreconcilable legal conflicts.
- Our foreign ownership structure may permanently preclude classified U.S. defense programs.
- Geopolitical tensions, international conflicts, or changes in U.S.-Israel relations could disrupt our supply chain and restrict our ability to distribute defense technologies.
- We are subject to stringent U.S. and international regulations governing defense technologies, and non-compliance could result in fines, loss of licenses, or restrictions on our operations.
- Risks Related to Our Financial Condition
- We lack the financial infrastructure required for defense contracting.
- Risks Related to Our Existing Capital Structure
- The outstanding warrants, convertible preferred stock, and our equity line of credit facility may result in substantial dilution to existing stockholders and depress our stock price.
- The price-based anti-dilution provisions in our convertible preferred stock may create a self-reinforcing cycle of dilution if our stock price declines.
- The substantial overhang of shares issuable upon conversion of preferred stock and exercise of outstanding warrants may depress our stock price regardless of our operating performance.
- We expect to issue additional shares of Common Stock or other securities in the future to fund acquisitions and operations, which would further dilute existing stockholders.
- Our stock price has been and may continue to be highly volatile, and investors may not be able to resell their shares at or above the price at which they purchased them.
- We are currently at risk of failing to maintain the minimum bid price required by Nasdaq Listing Rules.
- We might not be able to consummate the second tranche of our recent financing.
- Star has the right to require the Company to exchange the Investment Note for all the shares of Star then held by the Company if the Common Stock is delisted.
- There is no assurance that we will achieve and maintain profitability or that our revenue and business models will be successful.
- Changes in U.S. and foreign tax laws, as well as the application of such laws, could adversely impact our financial position and operating results.
- If our estimates or judgment relating to our critical accounting policies prove to be incorrect, our operating results could be adversely affected.
- The nature of our business requires the application of complex financial accounting rules, and there is limited guidance from accounting standard setting bodies. If financial accounting standards undergo significant changes, our operating results could be adversely affected.
- Business metrics and other estimates are subject to inherent challenges in measurement, and our business, operating results, and financial condition could be adversely affected by real or perceived inaccuracies in those metrics.
- We are subject to changes in financial reporting standards or policies, including as a result of choices made by us, which could materially adversely affect our reported results of operations and financial condition and may have a corresponding material adverse impact on capital ratios.
- As a public company, we are required to develop and maintain proper and effective internal controls over financial reporting, and any failure to maintain the adequacy of these internal controls may adversely affect investor confidence in our company and, as a result, the value of our stock.
- We might require additional capital to support business growth, and this capital might not be available or may require stockholder approval to obtain.
- Risks Related to Our Employees and Other Service Providers
- In the event of employee or service provider misconduct or error, our business may be adversely impacted.
- The loss of our chief executive officer, or our failure to attract and retain other highly qualified personnel in the future, could adversely impact our business, operating results, and financial condition.
- Our culture emphasizes innovation, and if we cannot maintain this culture as we grow, our business and operating results could be adversely impacted.
- Additional Risk Factors
- Cybersecurity requirements exceed our current capabilities.
- Environmental liabilities could exceed our resources.
- Menachem Shalom, our Chief Executive Officer and a director, beneficially owns a substantial percentage of our outstanding Common Stock and, if he exercises his warrants, would control a majority of the voting power of our Common Stock. This will allow him to exert significant control over corporate decisions and may discourage transactions that other stockholders may favor.
- The holder of our Series B Convertible Preferred Stock has additional voting power as compared to the holders of our Common Stock.
- We may never achieve profitability.
- Cyberattacks and security breaches of our systems, or those impacting our customers or third parties, could adversely impact our brand and reputation and our business, operating results and financial condition.
- Adverse economic conditions may adversely affect our business.
- We may be adversely affected by natural disasters, pandemics, and other catastrophic events, and by man-made problems such as war or terrorism, that could disrupt our business operations, and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster.
- Acquisitions, joint ventures or other strategic transactions create certain risks and may adversely affect our business, financial condition or results of operations.
- Delaware law and our Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws contain certain provisions, including anti-takeover provisions that limit the ability of stockholders to take certain actions and could delay or discourage takeover attempts that stockholders may consider favorable.
Legal proceedings
On March 3, 2026, the Company obtained a copy of a summons and complaint filed in the Supreme Court of the State of New York dated February 24, 2026 by Kingswood Capital Partners, LLC against Star 26 Capital, Inc., Nukkleus, Inc. and the Company. The complaint alleges that a success fee is due for an earned investment banking success fee arising from a transaction. The Company denies all the allegations and intends to vigorously defend such action, which it believes is without merit.
From time to time, we are subject to ordinary routine litigation incidental to our normal business operations. We are not currently a party to any material legal proceedings.
The opening of Item 3, Legal Proceedings.3
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGART3 Defense Inc. filings on SEC EDGAR
- 2SEC EDGART3 Defense Inc. filings on SEC EDGAR
- 3
- 4SEC EDGART3 Defense Inc. 10-K for fiscal 2024
- 5SEC EDGART3 Defense Inc. 10-K for fiscal 2024
- 6SEC EDGART3 Defense Inc. 10-K for fiscal 2022
- 7SEC EDGART3 Defense Inc. 10-K for fiscal 2019
- 8SEC EDGART3 Defense Inc. 10-K for fiscal 2020
- 9SEC EDGART3 Defense Inc. 10-K for fiscal 2021
- 10SEC EDGART3 Defense Inc. 10-Q for fiscal 2026
- 11SEC EDGART3 Defense Inc. 10-Q for fiscal 2026
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARRoy Cohen, Chief financial officer
- 18SEC EDGARTomer Nagar, Board member
- 19SEC EDGARBrian Ferrier, Board member
- 20SEC EDGARYebo Shen, Board member
- 21
- 22SEC EDGARExecutive or director change
- 23SEC EDGARNew debt or obligation
- 24SEC EDGAROther events
- 25
- 26SEC EDGARListing notice or transfer
- 27SEC EDGAROther events
- 28SEC EDGARShareholder vote
- 29
- 30SEC EDGAROther events
- 31
- 32SEC EDGARCompleted an acquisition or sale
- 33SEC EDGARShareholder vote
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42